Iqvia debuts clinical data analytics suite

By The Science Advisory Board staff writers

June 25, 2021 -- Iqvia has debuted its Clinical Data Analytics Suite, a new software as a service (SaaS)-based clinical data analytics platform.

The platform combines structured and unstructured data from clinical trials into a single, standardized setting. It pulls clinical data analytics from descriptive reports to provide predictive insights that improve trial safety for patients and quicken drug development, according to the firm. This aims to produce a scalable repository to help meet regulatory requirements and for stakeholders to investigate operational and clinical data.

The suite is interoperable with the rest of Iqvia's orchestrated clinical trial solutions and existing proprietary or third-party data archives and systems.

Myriad Genetics sells Myriad RBM to Q2 Solutions
Myriad Genetics is selling its Myriad RBM contract research services business to Q2 Solutions, a wholly owned subsidiary of Iqvia, for an undisclosed...
Iqvia debuts clinical data analytics intelligence platform
Iqvia has debuted a clinical data analytics intelligence platform to accelerate vaccine development and drug discovery.

Copyright © 2021 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter